Well known fact is that the anatomic pathology space is in transition. Learn what your lab needs to do now, to keep up with fast-paced industry changes and avoid being left behind!
Pathology laboratories continue to feel the pressure from the numerous challenges facing their businesses in today’s healthcare marketplace: Increased patient responsibility, changing lengths of stay in acute care facilities, the need for more comprehensive data, a demand for greater efficiency with declining reimbursements, dealing with hospital capitation programs, and changing standards in microbiology—just to name a few!
So what does this mean for your lab? It means first and foremost, that because of these sweeping changes to the pathology market, clinical and anatomic laboratories like yours must adapt to these changes—and quickly—in order to survive, and thrive.
What tools do you need—and where do you find the experts who can identify best practices for recognizing and dealing with today’s salient issues, so that you can leverage your best revenue opportunities based on your specific pathology business?
Get the answers you need when you register to attend “Strategies to Help You Secure Your Pathology Lab’s Financial Future,” held Wednesday, May 23 at 2 PM EDT. Listen as experts Harry Kanter, Louis Schnierer, and James Malter, MD, provide you with enlightened insights into the changes they believe are coming and share with you their recommendations on how to navigate these changes.
Kanter and Schnierer are principals at United WestLabs. UWL is a laboratory service company providing ancillary services and consulting services to laboratory outreach programs. It is the business of UWL to provide the missing or deficient pieces in the outreach laboratory space that allow hospital labs and other outreach programs to be competitive with the large commercial laboratories. UWL is expert at understanding the needs of outreach programs—whether in a hospital or commercial setting—in order to fill the gaps that are being addressed by their more mature, full-serviced competitors. In this context, Kanter and Schnierer have keen insights into what outreach programs need to do in order to be competitive, and will share ways to more successfully address patients—via more informative bills, better customer support, and more efficient billing practices, as well as providing tips that will allow your lab to become more competitive.
James Malter is the Chairman of Pathology at the University of Texas Southwestern Medical Center in Dallas, and Director of the Next Generation Sequencing Lab. Dr. Malter has written at length on laboratory issues and concerns, and possesses a comprehensive understanding of the ways in which pathologists now need to deal with the balance between hospital-based patients and outreach patients, nd will provide insights into how practices can best manage this delicate balance.
All three presenters will address current needs for data, and molecular testing. They will offer solutions on how to best address these issues in the pathology setting, and will be ready with insights on what you need and how to get it. You’ll hear clarification of the various issues from both a vertical and horizontal point of view, and gain a three-dimensional perspective of not only the issues, but also recommended solutions.
Whether you’re a hospital CFO, administrative laboratory director, pathologist, or lab manager—anyone who wants to improve pathology revenue and prosper despite the myriad changes occurring, and fully leverage the opportunities provided by these changes—this is one webinar you can’t afford to miss.
DATE: Wednesday, May 23, 2018
TIME: 2 PM EDT; 1 PM CDT; 12 PM MDT; 11 AM PDT
PLACE: Your computer
TO ORDER CD: Click here
For one low price—just $195 (through 5/16/18; $245 thereafter), you and your entire team at one location can take part in this fast-paced, insightful webinar. Best of all, you’ll be able to connect personally with our speakers when we open things up for questions from the audience.
Your Distinguished Presenters
Founder and CEO
United WestLabs, LLC
Santa Ana, CA
Harry Kanter is the founder, Chief Executive Officer, and majority shareholder of United WestLabs, Inc. (UWL), a healthcare services company based in Orange County, California. One of the most successful healthcare management companies in the country, UWL enters into management services agreements and/or joint venture agreements with major hospital organizations to provide hospitals with its proprietary turn-key business model, technology, expertise, billing systems, connectivity, and staffing necessary to implement and manage robust hospital-based, laboratory outreach programs. The company has implemented, managed, and staffed over 24 hospital-based laboratory outreach programs throughout the country.
As President of the Board of Directors of the Joseph H. Kanter Family Foundation, Kanter spends a great deal of time involved with philanthropy. Founded by his father (a WWII veteran, self-made entrepreneur, and cancer survivor), the Foundation has been working for over two decades to transform healthcare using health data. The Foundation mobilizes diverse organizations and people to share health data and harness the potential of analytics to empower learning from every health experience. It’s the first and only philanthropic foundation founded by a patient activist whose mission is to realize a patient-centered Learning Health System at national and global scales.
Prior to his involvement in healthcare, Kanter served as president of the Bank of Florida and board member of the National Banking Corporation of Florida. He is a trustee and partner at Kanter Investments Ltd., one of the largest landowners in south Florida.
Louis S. Schnierer, PhD
Vice President for Hospital Initiatives
United WestLabs, LLC
Santa Ana, CA
Schnierer has held senior clinical laboratory management positions with national hospital systems and executive positions in the commercial clinical laboratory industry including: Vice President Western Region with Smith Kline Beecham Clinical Laboratories and with Quest Diagnostics, Vice President Hospital Sales with Quest Diagnostics, and Senior Director Clinical Laboratory Services with Dignity Health. He has a Bachelor of Arts in Chemistry from Case Western Reserve University, a Master’s in Clinical Chemistry from Cleveland State University, and a Doctorate in Chemistry from Case Western Reserve University.
James S. Malter, MD
Professor and Senator Betty and Dr. Andy Andujar Distinguished Chairman of Pathology
University of Texas Southwestern Medical Center
Dr. Malter’s faculty career began in 1988 as an Assistant Professor of Pathology at Tulane, before moving to the University of Wisconsin-Madison in 1991 as an Assistant Professor of Pathology and Medical Director of the Transfusion Service in UW Hospital and Clinic, a post he held until 2011. Dr. Malter was promoted to Associate Professor with tenure in 1992, reaching Professor in 1997. He served as Interim Chairman of the Department of Pathology and Lab Medicine from 1993-95, participating in a leadership position as Chair of Strategic Planning and Retirement Committees for the newly created University of Wisconsin Medical Foundation, an integrated group practice of all faculty physicians. In 2004, Dr. Malter moved his research laboratory from UW School of Medicine to the UW Waisman Center for Intellectual Disabilities, a Eunice Kennedy Shriver National Institute of Child Health and Human Development IDDRC with 50 faculty from 26 different UW departments where he became Molecular Neuroscience Core Leader and Associate Director for Biological Sciences.
In 2011, he became the Senator Betty and Dr. Andy Andujar Distinguished Chairman of Pathology at the University of Texas Southwestern Medical Center, Dallas, TX, overseeing a department currently numbering 130 faculty with 4 major hospital affiliations. He remains clinically active, currently serving as Medical Director of the Next Generation Sequencing Lab. His research focuses principally on molecular mechanisms of gene expression and intracellular signaling in neurons and immune systems. He is the author of 122 peer reviewed publications including papers appearing in Science, Nature Immunology, Nature Communications, PNAS-USA, J Clinical Investigation, PloS Biology, Cell Reports and Science Signaling.
Malter has been a National Institutes of Health funded, Principal Investigator for the past 30 years, first on K08 (1988-91) and later R01 (1992-2014), P01 (2008-18), P30 (2004-11) and P50 (1997-2007) mechanisms. He was elected to the American Society of Clinical Investigation (ASCI) (1997) and has served on many NIH, National Science Foundation, Veterans Administration and Department of Defense review panels, including 3 years as founding Chair of the NIH, Center for Scientific Review Neural Oxidative Metabolism and Death Study Section. He is currently on the Board of Reviewing Editors of Science Signaling.